Evaluating Quality Indicators of Glioblastoma Care: Audit Results From an Indian Tertiary Care Cancer Center
Rimpa Basu Achari(Tata Medical Center), Tapesh Bhattacharyya(Tata Medical Center), Bivas Biswas(Tata Medical Center), Lateef Zameer(Tata Medical Center), Moses Arunsingh(Tata Medical Center), Mayur Parihar(Tata Medical Center), Anirban Das(Tata Medical Center), Love Goyal(Cancer Research UK), Saheli Saha(Tata Medical Center), Indranil Mallick(Tata Medical Center), Deepak Mishra(Tata Medical Center), Sanjoy Chatterjee(Tata Medical Center), Paromita Roy(Tata Medical Center), Santam Chakraborty(Tata Medical Center), Aditi Chandra(Tata Medical Center)
Cited by 2
Related Papers
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer
|Annals of Oncology|2022|138
Life Cycle Assessment of Solar Photovoltaic Microgrid Systems in Off-Grid Communities
|Environmental Science & Technology|2016|87
A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma
|Annals of Oncology|2024|33
Prioritizing Delivery of Cancer Treatment During a COVID-19 Lockdown: The Experience of a Clinical Oncology Service in India
|JCO Global Oncology|2021|11
Radiotherapy intensification for atypical and malignant meningiomas: A systematic review
|Neuro-Oncology Practice|2023|7